162
Views
7
CrossRef citations to date
0
Altmetric
Gastrointestinal Cancer

Saliva and plasma TIMP-1 in patients with colorectal cancer: a prospective study

, , , , , , & show all
Pages 1234-1241 | Received 01 Jun 2012, Accepted 06 Jul 2012, Published online: 08 Aug 2012
 

Abstract

Background and aims. A prospective cross-sectional study was designed to test if total levels of TIMP-1 in saliva and plasma correlated with the diagnosis of colorectal cancer (CRC) in a population with symptoms consistent with this disease. Materials and methods. Stimulated whole saliva and blood samples were collected from 161 individuals referred to colonoscopy with symptoms associated with CRC. The results of the examination, as well as previous and/or current other diseases were recorded. In a blinded study, the authors used an in-house TIMP-1 ELISA previously validated for use in saliva and plasma to determine total levels of TIMP-1. Results. Fifty-six of the patients (35%) were diagnosed with CRC. Plasma TIMP-1 levels were significantly elevated in CRC patients compared with patients with other, non-malignant diseases and individuals without disease. Significant differences in saliva TIMP-1 levels between CRC patients and individuals without CRC could not be demonstrated. In addition, no correlation was found between levels of TIMP-1 in plasma and saliva. Conclusion. Total levels of TIMP-1 in saliva do not reflect the presence of CRC, and TIMP-1 saliva measurements thus cannot substitute plasma TIMP-1 measurements in detection of CRC.

Acknowledgements

Research Nurses Anni Bech Jensen and Therese Juul are thanked for inclusion of patients and collection of blood and saliva samples. Grant support: The Kornerup Fund, The Aase and Ejnar Danielsen Fund, The Walter Christensen and O. Kristiane Christensen Fund, The Johannes Fog Fund, The Agnes and Poul Friis Fund, The Eva and Henry Fraenkel Fund, The Sophus and Astrid Jacobsen Fund, The Willy and Ingeborg Reinhard Fund and The Danish Cancer Society.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.